IL1B and myelofibrosis: Thus, contrary to the expectations from the complete genetic ablation of IL-1β in all tissues, pharmacological inhibition of IL-1β showed beneficial effects on myelofibrosis and course of the disease in VF mice comparable to the genetic ablation of IL-1β in hematopoietic tissues only.